Dh Frank Gommans1, G Etienne Cramer1, Jeannette Bakker2, Michelle Michels3, Hendrik-Jan Dieker1, Janneke Timmermans1, Michael A Fouraux4, Carlo Lm Marcelis5, Freek Wa Verheugt1, Marc A Brouwer1, Marcel Jm Kofflard6. 1. Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands. 2. Department of Radiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands. 3. Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands. 4. Department of Clinical Chemistry, Albert Schweitzer Hospital, Dordrecht, The Netherlands. 5. Department of Clinical Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands. 6. Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Abstract
OBJECTIVE: Areas of high signal intensity (HighT2) on T2-weighted cardiovascular magnetic resonance (CMR) imaging have been demonstrated in hypertrophic cardiomyopathy (HCM). It has been hypothesised that HighT2 may indicate active tissue injury in HCM. In this context, we studied HighT2 in relation to cardiac troponin. METHODS: Outpatient HCM patients without a history of coronary artery disease underwent CMR imaging at 1.5 T using T2-weighted, cine and late gadolinium enhancement (LGE) imaging to assess HighT2, left ventricular (LV) function, LV mass and the presence and extent of LGE. Highly sensitive cardiac troponin T (hs-cTnT) was assessed as a marker of injury, with hs-cTnT ≥14 and >3 ng/L defined as an elevated and detectable troponin. RESULTS: HighT2 was present in 28% of patients (28/101). An elevated hs-cTnT was present in 54% of patients with HighT2 (15/28) compared with 14% of patients without HighT2 (10/73) (p<0.001). Hs-cTnT was detectable in 96% of patients with HighT2 (27/28) compared with 66% of patients without HighT2 (48/73) (p=0.002). In case of an undetectable hs-cTnT, HighT2 was only seen in 4% (1/26). In addition, the extent of HighT2 was related with increasing hs-cTnT concentrations (Spearman's ρ: 0.42, p<0.001). CONCLUSIONS: In this CMR study of patients with HCM, we observed HighT2 in a quarter of patients, and demonstrated that HighT2 was associated with an elevated hs-cTnT. This observation, combined with the very high negative predictive value of an undetectable hs-cTnT for HighT2, provides supportive evidence for the hypothesis that HighT2 is indicative of recently sustained myocyte injury. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
OBJECTIVE: Areas of high signal intensity (HighT2) on T2-weighted cardiovascular magnetic resonance (CMR) imaging have been demonstrated in hypertrophic cardiomyopathy (HCM). It has been hypothesised that HighT2 may indicate active tissue injury in HCM. In this context, we studied HighT2 in relation to cardiac troponin. METHODS:Outpatient HCM patients without a history of coronary artery disease underwent CMR imaging at 1.5 T using T2-weighted, cine and late gadolinium enhancement (LGE) imaging to assess HighT2, left ventricular (LV) function, LV mass and the presence and extent of LGE. Highly sensitive cardiac troponin T (hs-cTnT) was assessed as a marker of injury, with hs-cTnT ≥14 and >3 ng/L defined as an elevated and detectable troponin. RESULTS: HighT2 was present in 28% of patients (28/101). An elevated hs-cTnT was present in 54% of patients with HighT2 (15/28) compared with 14% of patients without HighT2 (10/73) (p<0.001). Hs-cTnT was detectable in 96% of patients with HighT2 (27/28) compared with 66% of patients without HighT2 (48/73) (p=0.002). In case of an undetectable hs-cTnT, HighT2 was only seen in 4% (1/26). In addition, the extent of HighT2 was related with increasing hs-cTnT concentrations (Spearman's ρ: 0.42, p<0.001). CONCLUSIONS: In this CMR study of patients with HCM, we observed HighT2 in a quarter of patients, and demonstrated that HighT2 was associated with an elevated hs-cTnT. This observation, combined with the very high negative predictive value of an undetectable hs-cTnT for HighT2, provides supportive evidence for the hypothesis that HighT2 is indicative of recently sustained myocyte injury. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: D H Frank Gommans; G Etienne Cramer; Jeannette Bakker; Hendrik-Jan Dieker; Michelle Michels; Michael A Fouraux; Carlo L M Marcelis; Freek W A Verheugt; Janneke Timmermans; Marc A Brouwer; Marcel J M Kofflard Journal: Int J Cardiovasc Imaging Date: 2017-10-23 Impact factor: 2.357
Authors: Mahesh Bharath Keerthivasan; Sagar Mandava; Kevin Johnson; Ryan Avery; Rajesh Janardhanan; Diego R Martin; Ali Bilgin; Maria I Altbach Journal: J Cardiovasc Magn Reson Date: 2018-07-19 Impact factor: 5.364
Authors: Vincent L Aengevaeren; D H Frank Gommans; Hendrik-Jan Dieker; Janneke Timmermans; Freek W A Verheugt; Jeannette Bakker; Maria T E Hopman; Menko-Jan DE Boer; Marc A Brouwer; Paul D Thompson; Marcel J M Kofflard; G Etienne Cramer; Thijs M H Eijsvogels Journal: Med Sci Sports Exerc Date: 2019-10 Impact factor: 5.411
Authors: G Etienne Cramer; D H Frank Gommans; Hendrik-Jan Dieker; Michelle Michels; Freek Verheugt; Menko-Jan de Boer; Jeannette Bakker; Michael A Fouraux; Janneke Timmermans; Marcel Kofflard; Marc Brouwer Journal: Heart Date: 2020-01-30 Impact factor: 5.994
Authors: Céleste Chevalier; Miriam Wendner; Anna Suling; Ersin Cavus; Kai Muellerleile; Gunnar Lund; Paulus Kirchhof; Monica Patten Journal: Life (Basel) Date: 2022-08-16